IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Senores Pharmaceuticals IPO is a Book building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 582.11 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Ambit , Equirus Capital , Nuvama Wealth Management are the merchant bankers of Senores Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th July 2024.
Senores Pharmaceuticals IPO open date is 20th December 2024 and close date is 24th December 2024. IPO Allotment Date is 26th December 2024 and Listing date is 30th December 2024.
IPO
Size:
₹ 582.11 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Ambit Private
IPO by BRLM so far:
16
City:
Ahmedabad
IPO so far:
31
Revenue (annualised):
₹
366.70
cr. 
PE
Ratio:
28.21x
Average Sector PE Ratio: 25.12x
Senores Pharmaceuticals IPO size is ₹ 582.11 Cr. with IPO price of ₹ 391.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Ambit Private Limited is the book-running lead manager of the Senores Pharmaceuticals IPO. Link Intime India Private Limited is the Registrar for Senores Pharmaceuticals IPO.
Senores Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Senores Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on develops and manufactures a range of pharmaceutical products primarily for the regulated markets. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book building Issue method. Senores Pharmaceuticals IPO size is ₹ 582.11 Cr. with fresh issue size of ₹ 500.00 Cr. and Offer for sale being ₹ 82.11Cr.
The IPO allotment date for Senores Pharmaceuticals IPO is expected to be 26th December 2024, after the finalization of basis of allotment. Investors can check Senores Pharmaceuticals IPO allotment status on the registrars website, Link Intime India Private Limited . Senores Pharmaceuticals IPO refund dates are 27th December 2024.
Senores Pharmaceuticals IPO is expected to be listed on 30th December 2024.
The upper price band for the Senores Pharmaceuticals IPO is set at ₹ 391.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Senores Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Senores Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 24th December 2024. After submission, funds are blocked until the basis of allotment of Senores Pharmaceuticals IPO is finalised.
The merchant banker for Senores Pharmaceuticals IPO is Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited . Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Senores Pharmaceuticals IPO RHP for further details.
The registrar for Senores Pharmaceuticals IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Senores Pharmaceuticals IPO through their official website or helpline.
Senores Pharmaceuticals IPO was subscribed 97.86 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 582.11 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Ambit Private
IPO by BRLM so far:
16
City:
Ahmedabad
IPO so far:
31
Revenue (annualised):
₹ 362.00 cr.
PE
Ratio:
28.21x
Average Sector PE Ratio: 25.12x
Senores Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Senores Pharmaceuticals Financial Review Page
Merchant Banker(s) of Senores Pharmaceuticals IPO: Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited
Senores Pharmaceuticals IPO subscription was 97.86 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Senores Pharmaceuticals IPO listed at a listing price of 609.00 against the offer price of 391.00.
The current market price of Senores Pharmaceuticals is 532.90.
Why Us?
